Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biological Substance; Adverse Effect”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT05599347
What this trial is testing

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Who this might be right for
Crohn's Disease RelapseBiological Substance; Adverse Effect
Rambam Health Care Campus 180
Testing effectiveness (Phase 2)Study completedNCT01578070
What this trial is testing

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine

Who this might be right for
Healthy
Viscogel AB 130
Not applicableEnded earlyNCT04356404
What this trial is testing

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Who this might be right for
Occult Hepatitis BBiological Substance; Adverse EffectImmunosuppression
Chinese University of Hong Kong 68
Not applicableUnknownNCT05095844
What this trial is testing

National Vaccine Adverse Event Reporting Survey and Etiology

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Reaction+10 more
Neuroganics LLC 100,000

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation